SELLAS Life Sciences Group, Inc. SLS Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $16.02M-16.1% | $19.1M-20.5% | $24.01M+18.4% | $20.27M+29.3% | ||
| —— | —— | —— | —— | ||
| $28.27M-10.3% | $31.51M-16.8% | $37.87M-11.8% | $42.95M+30.6% | ||
| -$28.27M+10.3% | -$31.51M+16.8% | -$37.87M+9.7% | -$41.95M-65.8% | ||
| $1.41M+123% | $632K+19.5% | $529K-18.5% | $649K-85.1% | ||
| -$26.86M+13.0% | -$30.88M+17.3% | -$37.34M+9.6% | -$41.3M-99.5% | ||
| -$0.25+51.9% | -$0.52+61.8% | -$1.36+39.0% | -$2.23-67.7% | ||
| -$28.27M+10.3% | -$31.51M+16.8% | -$37.87M+9.7% | -$41.95M-65.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is SELLAS Life Sciences Group, Inc. profitable?
- SELLAS Life Sciences Group, Inc. is not currently profitable: it reported a net loss of $29.5M over the trailing twelve months, a -4130.1% net margin.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- Gross margin is 90.0% and operating margin is -4195.0%, with a -4130.1% net margin.
- What is SELLAS Life Sciences Group, Inc.'s earnings per share?
- SELLAS Life Sciences Group, Inc.'s diluted EPS over the trailing twelve months is $-0.23.
- Where does SELLAS Life Sciences Group, Inc.'s income statement data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.